isomethyleugenol has been researched along with Brain Stem Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Banda, A; Bayliss, J; Bian, Z; Blüml, S; Chinnaiyan, AM; Chung, C; Cieslik, M; Hawes, D; Judkins, AR; Koschmann, C; Lee, HJ; Lyssiotis, CA; Panwalkar, P; Pratt, D; Qin, T; Shan, M; Shotwell, JB; Sweha, SR; Tamrazi, B; Venneti, S; Wahl, DR; Werner, CK; Yadav, VN; Yang, F | 1 |
| Ehteda, A; Franshaw, L; Giorgi, FM; Gopalakrishnan, A; Gudkov, AV; Gurova, K; Haber, M; Hayden, E; Joshi, S; Kankean, A; Khan, A; Lehmann, R; Liu, J; Mayoh, C; Norris, MD; Pandher, R; Pang, CNI; Rouaen, JRC; Shen, S; Simon, S; Tang, Y; Tolhurst, O; Trebilcock, P; Tsoli, M; Ung, C; Vittorio, O; Ziegler, DS | 1 |
| Chang, JF; Chen, L; He, ZM; Jiang, CZ; Jing, YY; Kang, X; Liu, KN; Mao, ZY; Shen, Y; Sun, FL; Sun, J; Tang, HY; Wang, C; Wang, DL; Wei, HM; Wu, JY; Xu, RG; Yang, XM; Zeng, SY; Zhang, Y; Zhu, RB | 1 |
| Cheng, L; Daniels, DJ; Fang, D; Gan, H; Lee, JH; Sarkaria, JN; Zhang, Z; Zhou, H | 1 |
| Bender, S; Castel, D; Chen, S; Cho, YJ; Collins, VP; Ebinger, M; Grill, J; Gronych, J; Helin, K; Hovestadt, V; Højfeldt, JW; Jabado, N; Johann, PD; Jones, C; Jones, DT; Kool, M; Korshunov, A; Lichter, P; Lindroth, AM; Meyer, J; Milde, T; Monje, M; Monoranu, CM; Northcott, PA; Pfister, SM; Plass, C; Ponnuswami, A; Puget, S; Radlwimmer, B; Ryzhova, M; Schubert, S; Schuhmann, M; Seker-Cin, H; Stark, S; Sturm, D; Tang, Y; Truffaux, N; von Deimling, A; Wang, W; Witt, O; Zapatka, M | 1 |
| Andor, N; Chen, X; Fang, D; Gan, H; Gupta, N; Hashizume, R; Huang, X; Ihara, Y; James, CD; Lerner, R; Mueller, S; Ngo, V; Paris, PL; Petritsch, C; Solomon, D; Tom, MW; Waldman, TA; Zhang, Z | 1 |
| Abshiru, NA; Bartom, ET; Hashizume, R; Horbinski, CM; James, CD; Kelleher, NL; Lulla, RR; Ma, Q; Marshall, SA; Misharin, AV; Morgan, MA; Piunti, A; Rendleman, EJ; Saratsis, AM; Shilatifard, A; Takahashi, YH; Woodfin, AR | 1 |
7 other study(ies) available for isomethyleugenol and Brain Stem Neoplasms
| Article | Year |
|---|---|
Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas.
Topics: Animals; Brain Stem Neoplasms; Cell Line, Tumor; Diffuse Intrinsic Pontine Glioma; Epigenomics; Gene Expression Regulation, Neoplastic; Glycolysis; Histones; Humans; Lysine; Methylation; Mice, Inbred NOD; Mice, Knockout; Mice, Nude; Mice, SCID; Mutation; Transplantation, Heterologous | 2020 |
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG.
Topics: Acetylation; Animals; Antineoplastic Agents; Brain Stem Neoplasms; Carbazoles; Cell Cycle Proteins; Cell Line, Tumor; Child; Chromatin; Diffuse Intrinsic Pontine Glioma; DNA-Binding Proteins; Drug Synergism; E2F1 Transcription Factor; Epigenesis, Genetic; Epigenome; High Mobility Group Proteins; Histones; Humans; Methylation; Mice; Neuroglia; Panobinostat; Primary Cell Culture; Retinoblastoma Protein; Signal Transduction; Survival Analysis; Transcription Factors; Transcriptional Elongation Factors; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2021 |
Histone H3K27 methylation modulates the dynamics of FANCD2 on chromatin to facilitate NHEJ and genome stability.
Topics: Brain Stem Neoplasms; Cell Line; Chromatin; DNA End-Joining Repair; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Fanconi Anemia Complementation Group D2 Protein; Fibroblasts; Genomic Instability; Glioma; HEK293 Cells; Histones; Humans; Methylation; Tumor Suppressor p53-Binding Protein 1 | 2018 |
H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers.
Topics: Brain Stem Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cellular Reprogramming; Enhancer Elements, Genetic; Epigenomics; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Methylation; Mutation; Neuroglia; Polycomb-Group Proteins; Promoter Regions, Genetic; WT1 Proteins | 2018 |
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas.
Topics: Brain Neoplasms; Brain Stem Neoplasms; Cell Line, Tumor; Child; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, Dominant; Glioblastoma; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Molecular Sequence Data; Mutation, Missense; Neoplasm Proteins; Polycomb Repressive Complex 2; Protein Binding; Protein Processing, Post-Translational; Transcription Factors; Transcription, Genetic | 2013 |
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
Topics: Animals; Apoptosis; Benzazepines; Brain Stem Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Methylation; Mice; Pyrimidines; Xenograft Model Antitumor Assays | 2014 |
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.
Topics: Acetylation; Animals; Azepines; Brain Stem Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromatin; Epigenomics; Gene Expression Regulation, Neoplastic; Glioma; Histone Code; Histones; Humans; Methylation; Mice; Molecular Targeted Therapy; Mutation; Neurogenesis; Nucleosomes; Polycomb Repressive Complex 2; Protein Transport; RNA-Binding Proteins; Triazoles; Xenograft Model Antitumor Assays | 2017 |